ATAD2 and hepatocellular carcinoma: To our knowledge, this is the first evidence of ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for HCC development, and altered components of this regulatory loop may represent attractive therapeutic targets.